Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.6%

284 terminated/withdrawn out of 2083 trials

Success Rate

81.7%

-4.8% vs industry average

Late-Stage Pipeline

7%

154 trials in Phase 3/4

Results Transparency

43%

548 of 1270 completed trials have results

Key Signals

294 recruiting548 with results159 terminated125 withdrawn

Enrollment Performance

Analytics

N/A
916(51.3%)
Phase 2
339(19.0%)
Phase 1
269(15.1%)
Early Phase 1
109(6.1%)
Phase 3
77(4.3%)
Phase 4
77(4.3%)
1787Total
N/A(916)
Phase 2(339)
Phase 1(269)
Early Phase 1(109)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2083)

Showing 20 of 2083 trials
NCT05753410Not ApplicableCompleted

App-Based Mindfulness Training for Individuals With Anorexia Nervosa and Bulimia Nervosa

Role: collaborator

NCT04645602Early Phase 1Recruiting

Merck IIT: RRP Pembro and Lenvatinib

Role: lead

NCT04860336Completed

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Role: collaborator

NCT06006143Phase 2Active Not Recruiting

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2

Role: lead

NCT06323824Phase 4Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Role: lead

NCT06004830Phase 2Active Not Recruiting

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1

Role: lead

NCT06074068Not ApplicableRecruiting

Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

Role: lead

NCT05067621Phase 2Active Not Recruiting

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease

Role: lead

NCT07172256Phase 2Not Yet Recruiting

CUE-101with Pembrolizumab for LA-HPV+HNSCCs

Role: lead

NCT07526948Phase 4Not Yet Recruiting

Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV

Role: collaborator

NCT04334707Recruiting

Kidney Precision Medicine Project

Role: collaborator

NCT05996185Phase 2Recruiting

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

Role: lead

NCT07201402Phase 2Not Yet Recruiting

Long Term Evaluation of Scapular-inserted Contraceptive Implants

Role: lead

NCT05712707Phase 1Active Not Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Role: collaborator

NCT04587791Early Phase 1Recruiting

Cannabidiol in Opioid Use Disorder and Chronic Pain

Role: lead

NCT07529509Not ApplicableNot Yet Recruiting

Abriendo Caminos: Engaging Latinos

Role: lead

NCT06691217Phase 2Recruiting

Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

Role: collaborator

NCT06996652Phase 2Not Yet Recruiting

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Role: lead

NCT03069326Phase 2Active Not Recruiting

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Role: collaborator

NCT07525258Not ApplicableNot Yet Recruiting

Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)

Role: lead